Form 4: PMV Pharmaceuticals Executive Modifies Stock Option Holdings Through Exchange Program

Deepika Jalota, Chief Development Officer of PMV Pharmaceuticals, participated in an option exchange program, resulting in the cancellation and replacement of several employee stock options.

Summary

• Deepika Jalota, Chief Development Officer of PMV Pharmaceuticals, filed a Form 4 detailing changes in her beneficial ownership of company stock.
• On August 13, 2024, Jalota participated in an option exchange program.
• As part of this program, existing stock options were cancelled and replaced with new options.
• Specifically, options for 22,674 shares (originally granted on May 12, 2021, with an exercise price of $28.33), 68,100 shares (originally granted on February 10, 2022, with an exercise price of $16.29), and 125,000 shares (originally granted on May 12, 2023, with an exercise price of $5.7) were cancelled.
• In exchange, Jalota received new options for the same number of shares (22,674, 68,100 and 125,000), but with a new exercise price of $1.48 per share for the first two and $1.49 for the last.
• The vesting schedules for the new options vary, with some vesting immediately and others vesting over time.

Sentiment

Score: 6

Explanation: The document itself is neutral, simply reporting a transaction. The option exchange could be seen as a positive sign of the company trying to retain talent, but it also suggests the original options were less valuable due to stock performance.

Positives

• The option exchange program may incentivize the executive by providing options with a lower exercise price.

Industry Context

Option exchange programs are sometimes used by companies to re-incentivize employees, particularly when the stock price has declined significantly since the original options were granted. This helps retain talent and align employee interests with those of shareholders.

Comparison to Industry Standards

• Option exchange programs are a fairly common practice in the pharmaceutical industry, especially for companies with volatile stock prices.
• Similar programs have been implemented by companies like Novavax and Sorrento Therapeutics to retain key employees and boost morale during challenging periods.
• The specific terms of the exchange, such as the new exercise price and vesting schedule, are typically tailored to the individual company's circumstances and the employee's role.

Stakeholder Impact

• Shareholders may view the option exchange as a way to incentivize management and align their interests with the company's success.
• Employees who received new options may be more motivated due to the lower exercise price.

Key Dates